Bio Path Stock Forecast - Daily Balance Of Power
| BPTH Stock | USD 1.35 0.31 29.81% |
Bio Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Bio Path's historical fundamentals, such as revenue growth or operating cash flow patterns.
Bio |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.5714 | (0.25) |
| Check Bio Path Volatility | Backtest Bio Path | Trend Details |
Bio Path Trading Date Momentum
| On December 19 2024 Bio Path Holdings was traded for 1.49 at the closing time. The top price for the day was 3.39 and the lowest listed price was 1.33 . The trading volume for the day was 113.6 M. The trading history from December 19, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 122.39% . The overall trading delta against the current closing price is 82.09% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Bio Path to competition |
Other Forecasting Options for Bio Path
For every potential investor in Bio, whether a beginner or expert, Bio Path's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bio. Basic forecasting techniques help filter out the noise by identifying Bio Path's price trends.Bio Path Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Path stock to make a market-neutral strategy. Peer analysis of Bio Path could also be used in its relative valuation, which is a method of valuing Bio Path by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bio Path Holdings Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Bio Path's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Bio Path's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bio Path Market Strength Events
Market strength indicators help investors to evaluate how Bio Path stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Path shares will generate the highest return on investment. By undertsting and applying Bio Path stock market strength indicators, traders can identify Bio Path Holdings entry and exit signals to maximize returns.
| Accumulation Distribution | 543253.0 | |||
| Daily Balance Of Power | 0.6458 | |||
| Rate Of Daily Change | 1.3 | |||
| Day Median Price | 1.22 | |||
| Day Typical Price | 1.26 | |||
| Price Action Indicator | 0.29 | |||
| Period Momentum Indicator | 0.31 |
Bio Path Risk Indicators
The analysis of Bio Path's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bio Path's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.47 | |||
| Semi Deviation | 5.21 | |||
| Standard Deviation | 16.75 | |||
| Variance | 280.71 | |||
| Downside Variance | 37.57 | |||
| Semi Variance | 27.1 | |||
| Expected Short fall | (9.66) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Bio Path Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Path's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Path Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Path Holdings Stock:Check out Historical Fundamental Analysis of Bio Path to cross-verify your projections. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.34) | Return On Assets (1.40) | Return On Equity (3.66) |
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.